A network-based approach to identify expression modules underlying rejection in pediatric liver transplantation

Area of Science:

• Immunology
• Genomics
• Computational Biology

Background:

• Pediatric liver transplant recipients face challenges in selecting immunosuppressants to prevent organ rejection.
• Current diagnostic methods lack validated blood-based biomarkers for monitoring rejection in pediatric liver transplant patients.

Purpose of the Study:

• To discover and validate pre- and post-transplant molecular signatures for predicting liver transplant rejection in children.
• To develop a machine learning approach for identifying targetable pathways for personalized immunosuppression.

Main Methods:

• Integrative machine learning analysis of transcriptomics data combined with the human protein interactome.
• Identification of network module signatures underlying transplant rejection.
• Individual-specific signature identification for drug targeting.

Main Results:

• Discovery and validation of distinct pre- and post-transplant transcriptomic signatures of rejection.
• Identification of network modules, offering a more robust and multivariate approach than traditional gene signatures.
• Identification of individual-specific signatures actionable with existing or repurposed drugs.

Conclusions:

• The developed molecular predictor can aid in personalized adjustment of immunosuppressive drug regimens for pediatric liver transplant recipients.
• This approach addresses the need for validated biomarkers and offers a pathway to improved, rejection-free transplant outcomes in children.